Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
14.00
Dollar change
+0.15
Percentage change
1.08
%
IndexRUT P/E- EPS (ttm)-1.08 Insider Own22.80% Shs Outstand57.82M Perf Week0.36%
Market Cap861.00M Forward P/E306.28 EPS next Y0.05 Insider Trans-12.08% Shs Float47.48M Perf Month-3.71%
Income-61.69M PEG- EPS next Q-0.15 Inst Own74.97% Short Float10.48% Perf Quarter39.58%
Sales202.09M P/S4.26 EPS this Y33.12% Inst Trans0.64% Short Ratio7.54 Perf Half Y57.84%
Book/sh-0.36 P/B- EPS next Y110.92% ROA-33.62% Short Interest4.98M Perf Year66.47%
Cash/sh1.02 P/C13.70 EPS next 5Y16.50% ROE-1279.29% 52W Range7.07 - 15.43 Perf YTD32.95%
Dividend Est.- P/FCF- EPS past 5Y10.81% ROI-59.04% 52W High-9.28% Beta1.45
Dividend TTM- Quick Ratio2.10 Sales past 5Y44.65% Gross Margin67.00% 52W Low98.02% ATR (14)0.56
Dividend Ex-Date- Current Ratio2.33 EPS Y/Y TTM18.34% Oper. Margin-17.87% RSI (14)53.71 Volatility3.06% 4.35%
Employees273 Debt/Eq- Sales Y/Y TTM35.98% Profit Margin-30.52% Recom1.12 Target Price22.29
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q11.67% Payout- Rel Volume1.02 Prev Close13.85
Sales Surprise1.34% EPS Surprise-0.65% Sales Q/Q39.76% EarningsMar 07 AMC Avg Volume659.92K Price14.00
SMA20-1.31% SMA504.30% SMA20039.34% Trades Volume672,643 Change1.08%
Date Action Analyst Rating Change Price Target Change
Jan-29-24Upgrade Barclays Equal Weight → Overweight $10 → $16
Jun-23-22Initiated Needham Buy $18
May-12-22Upgrade Barclays Underweight → Equal Weight $8 → $10
Jan-20-22Upgrade Truist Hold → Buy $11
May-06-21Upgrade Mizuho Neutral → Buy $15
Apr-08-21Reiterated H.C. Wainwright Buy $20 → $22
Feb-24-21Downgrade Truist Buy → Hold $12
Jul-07-20Downgrade Mizuho Buy → Neutral $8 → $3
Feb-06-20Resumed Mizuho Buy
Nov-26-19Initiated SVB Leerink Outperform $25
Mar-26-24 08:00AM
Mar-14-24 07:04AM
Mar-13-24 09:55AM
Mar-11-24 07:00AM
Mar-08-24 04:05PM
03:24PM Loading…
03:24PM
12:30PM
Mar-07-24 10:34PM
09:53PM
04:05PM
Mar-04-24 08:28PM
Mar-01-24 08:30AM
Feb-27-24 08:30AM
Feb-22-24 04:30PM
Feb-09-24 04:05PM
09:10PM Loading…
Feb-02-24 09:10PM
Jan-16-24 05:28PM
Jan-12-24 04:23PM
Jan-09-24 06:21PM
Jan-04-24 04:05PM
Dec-20-23 08:00AM
Dec-08-23 04:30PM
Nov-13-23 09:08AM
Nov-10-23 05:16PM
Nov-07-23 04:16PM
Nov-06-23 08:45AM
Nov-01-23 08:45AM
Oct-25-23 08:45AM
08:45AM
Oct-08-23 06:41PM
04:05PM Loading…
Sep-29-23 04:05PM
Sep-13-23 04:10PM
Sep-09-23 01:03PM
Sep-03-23 05:29AM
Aug-29-23 08:45AM
Aug-27-23 07:20PM
Aug-23-23 06:53PM
Aug-21-23 08:45AM
Aug-08-23 09:15AM
08:45AM
Aug-02-23 05:45PM
04:05PM
Jul-27-23 11:42AM
08:45AM
Jul-26-23 10:02AM
08:45AM
Jul-19-23 08:45AM
Jul-15-23 07:30AM
Jun-29-23 09:00AM
Jun-22-23 08:45AM
Jun-08-23 04:05PM
Jun-02-23 06:38AM
May-16-23 01:44PM
May-09-23 05:25PM
04:01PM
04:01PM
May-05-23 01:37PM
Apr-17-23 11:05AM
Apr-04-23 10:39AM
Mar-11-23 06:38AM
Mar-09-23 10:12AM
Mar-08-23 05:35PM
04:05PM
Feb-28-23 08:45AM
Feb-27-23 08:45AM
Feb-22-23 08:45AM
Feb-10-23 11:07AM
Jan-31-23 08:45AM
Jan-30-23 12:02PM
07:09AM
Jan-28-23 08:00AM
Jan-23-23 09:00AM
08:00AM
Jan-20-23 01:54PM
Jan-19-23 01:15PM
Jan-18-23 08:45AM
Jan-03-23 10:03AM
Dec-08-22 08:45AM
Dec-07-22 10:00AM
09:17AM
Nov-10-22 05:57AM
Nov-08-22 06:25PM
04:05PM
Nov-02-22 08:45AM
Oct-25-22 08:45AM
Oct-04-22 08:20AM
Sep-21-22 08:45AM
Sep-20-22 09:03AM
Sep-18-22 07:30AM
Sep-09-22 02:30PM
Sep-06-22 04:05PM
Aug-30-22 08:15AM
Aug-29-22 05:45AM
Aug-24-22 08:14AM
Aug-22-22 08:37AM
Aug-02-22 09:25AM
08:05AM
Jul-19-22 08:45AM
08:37AM
Jul-12-22 08:47AM
Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November 2012 and is headquartered in Newport Beach, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MOATAZEDI DAVIDSee RemarksMar 19 '24Sale13.9296,5661,344,604695,850Mar 21 06:08 PM
Avelar RuiSee RemarksMar 19 '24Sale13.9227,603384,350372,288Mar 21 06:09 PM
Beaver SandraChief Financial OfficerMar 19 '24Sale13.925,67278,978154,201Mar 21 06:09 PM
MOATAZEDI DAVIDSee RemarksFeb 22 '24Sale13.087,706100,804792,416Feb 23 08:27 PM
Beaver SandraChief Financial OfficerFeb 22 '24Sale13.081,82123,821159,873Feb 23 08:27 PM
Avelar RuiSee RemarksFeb 22 '24Sale13.081,82123,821399,891Feb 23 08:27 PM
Parschauer Karah HerdmanDirectorJan 30 '24Sale13.1411,931156,73331,243Feb 02 04:57 PM
MOATAZEDI DAVIDSee RemarksDec 08 '23Sale9.7331,300304,505603,944Dec 08 06:15 PM
MOATAZEDI DAVIDSee RemarksDec 06 '23Sale10.0951,348517,891635,244Dec 08 06:15 PM
Medytox Inc.Former 10% OwnerOct 16 '23Sale7.501,690,66312,679,9723,381,326Oct 18 04:21 PM
Beaver SandraChief Financial OfficerSep 06 '23Sale9.703,17830,827113,368Sep 08 08:54 PM
MOATAZEDI DAVIDSee RemarksAug 16 '23Sale10.2714,778151,770686,592Aug 16 08:25 PM
Beaver SandraChief Financial OfficerAug 16 '23Sale10.272,21122,707116,546Aug 16 08:25 PM
Avelar RuiSee RemarksAug 16 '23Sale10.272,21122,707353,386Aug 16 08:25 PM
Malik VikramDirectorAug 15 '23Buy7.41174,9671,296,505275,550Aug 15 04:34 PM